"By combining our MEAI platform with PEA from our partners at NeuroThera Labs, we are positioning ourselves to address the escalating demand for effective, tolerable and safe treatments in the obesity and liver health space."
clearmind-cmnd.short.gy/patent-weightl…
$CMND #MEAI#GLP1
The Phase I/IIa clinical trial is a multinational, multicenter study designed to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of CMND-100 in patients with moderate to severe AUD.
clearmind-cmnd.short.gy/third-cohort#CMND#MEAI $CMND
Clearmind’s novel treatment candidates are backed by rigorous science and well-defined intellectual property. Check out this link for a deep dive into the science behind MEAI and the patents that protect it and other treatments: clearmindmedicine.com/science-and-ip#MEAI#CMND#Science